Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Description | Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device (Sandoz Ltd) |
BNF code | 0302000X0BBAAAA |
Virtual Medicinal Product | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device |
Name | Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device |
Abbreviated name | Atectura Breezhaler 125microg/62.5microg inhalation pdr caps |
Date of name applicability | 24 Nov 2020 |
Previous name | Atectura Breezhaler 125micrograms/62.5 micrograms inhalation powder capsules with device |
Supplier | Sandoz Ltd |
Current licensing authority | Medicines - MHRA/EMA |
EMA additional monitoring | ✗ |
Parallel import | ✗ |
Restrictions on availability | None |
Excipients | |
---|---|
Ingredient | Lactose |
Licensed Route | |
Licenced route | Inhalation |
Actual Medicinal Product Packs | |
Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device (Sandoz Ltd) 30 capsule 3 x 10 capsules |
dm+d data retrieved from TRUD: release NHSBSA_8.1.0_20220808000001, imported on 8th August 2022 at 04:49:10.